Literature DB >> 6447668

Generation of autologous mixed leucocyte reactions during the course of infection with Theileria parva (East Coast Fever) in cattle.

D L Emery, W I Morrison.   

Abstract

During the course of East Coast Fever (ECF) in cattle, an examination was made of the evolution of autologous mixed leucocyte reactions (MLR) between normal responder lymphocytes collected prior to infection and stimulators cells prepared from infected lymphoid organs at intervals after challenge. Proliferative responses were induced by spleen cells, peripheral blood leucocytes (PBL) and cells (LNC) from both regional and distant lymph nodes. The proliferation by normal PBL in response to LNC occurred earlier in the course of infection and was of greater magnitude than the MLRs induced by spleen cells and PBL. The ability of LNC to stimulate an autologous MLR declined after 14 days post-challenge, whereas both spleen cells and PBL were stimulatory for normal PBL until the death of the host at 18--20 days after challenge. The results imply that the earliest stimulation to the lymphocyes involved in cell-mediated immunity is afforded in the absence of detectable macroschizonts (less than 0 . 1 %). The inductive signal(s) probably emanates from transformational or parasite-coded antigens on blast cells which first appear around 8--10 days after infection. The continual generation of infected lymphoblasts may initiate proliferation of additional leucocytes involved in cell-mediated immunity at later intervals during the course of infection. The capacity of the host to mount humoral and cell-mediated responses to the infected cells is late in relation to the pathogenesis and outcome of the infection.

Entities:  

Mesh:

Year:  1980        PMID: 6447668      PMCID: PMC1457984     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Immune responses to LCM virus infection in vivo and in vitro. Mechanisms of immune-mediated disease.

Authors:  G A Cole; E D Johnson
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  MODE OF MULTIPLICATION OF THEILERIA IN CULTURES OF BOVINE LYMPHOCYTIC CELLS.

Authors:  L HULLIGER; K H WILDE; C G BROWN; L TURNER
Journal:  Nature       Date:  1964-08-15       Impact factor: 49.962

3.  Initial studies on the properties of a bovine lymphoid cell culture line infected with Theileria parva.

Authors:  W P Duffus; G G Wagner; J M Preston
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

4.  Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells.

Authors:  J Viallat; E Svedmyr; E Yefenof; G Klein; O Weiland
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

5.  Cell-mediated immunity to Theileria-transformed cell lines.

Authors:  T W Pearson; L B Lundin; T T Dolan; D A Stagg
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

6.  Activated human T lymphocytes display new surface glycoproteins.

Authors:  L C Andersson; C G Gahmberg; A K Kimura; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Studies on colostral antibodies to Theileria parva using the indirect fluorescent antibody test.

Authors:  M J Burridge; C D Kimber
Journal:  Z Tropenmed Parasitol       Date:  1973-09

8.  Leucocyte migration inhibition as a model for the demonstration of sensitized cells in East Coast fever.

Authors:  S I Muhammed; G G Wagner; L H Lauerman
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

9.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Autosensitization in vitro.

Authors:  I R Cohen; A Globerson; M Feldman
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

  10 in total
  8 in total

1.  The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction.

Authors:  R Palacios; L Claesson; G Möller; P A Peterson; E Möller
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

2.  Characterization of the effector cell that mediates cytotoxicity against Theileria parva (East Coast fever) in immune cattle.

Authors:  D L Emery; T Tenywa; R M Jack
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

3.  Proliferation and lymphocyte stimulatory capacity of Theileria-infected lymphoblastoid cells before and after the elimination of intracellular parasites.

Authors:  M Pinder; S Kar; K S Withey; L B Lundin; G E Roelants
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

4.  Immune responses of cattle to Theileria parva (East Coast fever): specificity of cytotoxic cells generated in vivo and in vitro.

Authors:  D L Emery; S K Kar
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

5.  Expression of Tac antigen component of bovine interleukin-2 receptor in different leukocyte populations infected with Theileria parva or Theileria annulata.

Authors:  D A Dobbelaere; T D Prospero; I J Roditi; C Kelke; I Baumann; M Eichhorn; R O Williams; J S Ahmed; C L Baldwin; H Clevers
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Bovine immune response to Theileria parva: neutralizing antibodies to sporozoites.

Authors:  A J Musoke; V M Nantulya; G Buscher; R A Masake; B Otim
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Cell-mediated immune responses to Theileria parva (East Coast fever) during immunization and lethal infections in cattle.

Authors:  D L Emery; E M Eugui; R T Nelson; T Tenywa
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

8.  Identification of Theileria lestoquardi Antigens Recognized by CD8+ T Cells.

Authors:  Shan Goh; Daniel Ngugi; Regina Lizundia; Isabel Hostettler; Kerry Woods; Keith Ballingall; Niall D MacHugh; W Ivan Morrison; Willie Weir; Brian Shiels; Dirk Werling
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.